Stern, Yale, or Cornell MBA: Which is the best for ER?
Which of the three MBA programs has the best placement for equity research upon graduation? Also, what experience or credentials should one have to break into ER post-MBA?
Which of the three MBA programs has the best placement for equity research upon graduation? Also, what experience or credentials should one have to break into ER post-MBA?
+81 | Q&A - Buyside Equity Research Analyst/PM | 29 | 3d | |
+32 | How the heck do you learn all of this stuff? | 5 | 1w | |
+28 | My experience on the sell side | 20 | 2w | |
+28 | Getting Frustrated | 10 | 3w | |
+24 | Clues in Financial Reporting Analysis | 7 | 10h | |
+18 | Biotech ER vs IB | 16 | 3w | |
+17 | Am i fairly compensated? | 9 | 1d | |
+14 | Heard they don’t model at Oppenheimer | 10 | 2w | |
+14 | Data Science to PM | 8 | 6d | |
+12 | ER - Remote Jobs? | 8 | 3d |
Career Resources
The CFA designation.
Stern would be great, primarily due to NYC proximity. However all three would suffice.
If I were in your shoes I'd opt for Yale - I really can't quite explain or substantiate the following claim, but I really feel like Yale SOM is on the come up.
Compare the employment reports to see which places the most graduates into ER.
Stern-> Cornell-> Yale
Stern has as strong a sell side brand as Columbia (Buyside is a whole other topic) Johnson also has a strong sell side brand, but mostly for IB. Although I have met several Johnson lead analysts on the street Yale SOM doesnt have that strong of a sell side presence.
Also, I am assuming that you are not in the 'business' and using the MBA to make the move. In which case, a CFA aint gonna do sh*t for you (i.e. disregard the first response in this post).
No,
I was saying that the CFA alone would not help a career switcher land into ER. But a career switcher with a top MBA+CFA? Absolutely.
I strongly considered Yale SOM, but their sell side and long-only recruiting is not that strong. This may come as a bit of surprise since they seem to place well for IBD and also private equity. I met the president of their investment management club and he had pretty negative things to say about Yale's placement, particularly on the buy side.
I actually had the same impression. I think Yale SOM will be much more highly ranked in the next 5-10 years. However, it's still a top 15-20 school and it will take time to change that.
Another thing to consider is that New Haven is a dump, which really turned me off from applying to Yale.
This is good advice too:
Stern>Cornell>Yale
Cupiditate tempore illo est quia aliquid officia aliquid sed. Dolores voluptatem rerum iste sed deserunt laboriosam tenetur maiores. Adipisci ut qui aliquid.
Ad dicta dolorem ut debitis soluta a. Tempora aperiam voluptatum fugiat autem et eos eum.
Dolor iusto esse dolores et. Dolorum aut esse quis voluptatibus. Eius enim impedit ut modi nesciunt.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...